Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Caspofungin.

P H Chandrasekar1, E K Manavathu

  • 1Department of Medicine, Wayne State University Detroit, MI 48201, USA. pchandrasekar@intmed.wayne.edu

Drugs of Today (Barcelona, Spain : 1998)
|February 13, 2003
PubMed
Summary

Caspofungin, a new echinocandin antifungal, offers a novel treatment for invasive fungal infections. This review covers its chemistry, action, efficacy, and safety in patients.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection and pharmacokinetics of a cytomegalovirus (CMV) DNA plasmid in human plasma during a clinical trial of an intramuscular CMV vaccine in hematopoietic stem cell transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2014
Same author

Vaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls.

Transplant infectious disease : an official journal of the Transplantation Society·2013
Same author

In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.

Diagnostic microbiology and infectious disease·2012
Same author

Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient.

Bone marrow transplantation·2011
Same author

Clinical impact of the use of 16S rRNA sequencing method for the identification of "difficult-to-identify" bacteria in immunocompromised hosts.

Transplant infectious disease : an official journal of the Transplantation Society·2011
Same author

Weissella confusa: an unexpected cause of vancomycin-resistant gram-positive bacteremia in immunocompromised hosts.

Transplant infectious disease : an official journal of the Transplantation Society·2010

Area of Science:

  • Pharmacology and Infectious Diseases

Background:

  • Limited systemic antifungal agents exist for invasive fungal infections.
  • Growing need for novel antifungal drugs identified.

Purpose of the Study:

  • To review caspofungin, the first echinocandin antifungal.
  • To detail its chemistry, mechanism of action, and preclinical/clinical data.

Main Methods:

  • Literature review of caspofungin's properties and applications.
  • Analysis of in vitro and animal model studies.
  • Evaluation of clinical pharmacokinetics, efficacy, and safety data.

Main Results:

  • Caspofungin represents a new class of antifungals (echinocandins).
  • Demonstrated activity in vitro and in animal models.
  • Clinical data on pharmacokinetics, efficacy, and safety presented.

Conclusions:

  • Caspofungin is a significant advancement in treating invasive fungal infections.
  • Provides a new therapeutic option with a unique mechanism.